4 results
To investigate trastuzmab-paclitaxel in EGFR-mutated NSCLC patients who have overexpression of HER2 and who have progressed on standard TKI-treatment
The proposed Study J2G-MC-JZJC (hereafter referred to as JZJC) will evaluate selpercatinib in comparison to platinum-based (carboplatin or cisplatin) and pemetrexed therapy with or without pembrolizumab in patients with locally advanced or…
Identifying the fixation and migration patterns of the G7 BiSpherical acetabular system combined with the GTS stem (Zimmer Biomet) prosthesis in vivo, using model based roentgen radiostereophotogrammetric (mRSA) analysis over a period of 10 years.
To compare EFS of participants in the primary analysis population with Stage II-IIIA RET fusion-positive NSCLC treated with selpercatinib versus placebo.